These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 16504678

  • 1. IgA nephropathy in kidney allograft recipients-therapeutic perspective.
    Pazik J, Baczkowska T, Lewandowski Z, Lewandowska D, Ostrowska J, Perkowska Ptasińska A, Mróz A, Miszewska-Szyszkowska D, Rowinski W, Durlik M.
    Transplant Proc; 2006; 38(1):112-4. PubMed ID: 16504678
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Does angiotensin blockade influence graft outcome in renal transplant recipients with IgA nephropathy?
    Courtney AE, McNamee PT, Nelson WE, Maxwell AP.
    Nephrol Dial Transplant; 2006 Dec; 21(12):3550-4. PubMed ID: 16968729
    [Abstract] [Full Text] [Related]

  • 5. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.
    Clin Transplant; 2005 Dec; 19 Suppl 14():41-8. PubMed ID: 15955168
    [Abstract] [Full Text] [Related]

  • 6. Risk factors and prognosis for proteinuria in renal transplant recipients.
    Sancho A, Gavela E, Avila A, Morales A, Fernández-Nájera JE, Crespo JF, Pallardo LM.
    Transplant Proc; 2007 Sep; 39(7):2145-7. PubMed ID: 17889119
    [Abstract] [Full Text] [Related]

  • 7. Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.
    Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT.
    Med J Malaysia; 2007 Jun; 62(2):109-13. PubMed ID: 18705440
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Jun; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 Jun; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tonsillectomy does not prevent a progressive course in IgA nephropathy.
    Rasche FM, Schwarz A, Keller F.
    Clin Nephrol; 1999 Mar; 51(3):147-52. PubMed ID: 10099887
    [Abstract] [Full Text] [Related]

  • 15. New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.
    Yakupoğlu U, Baranowska-Daca E, Suki WN, Truong LD.
    Transplant Proc; 2004 Mar; 36(1):139-43. PubMed ID: 15013326
    [Abstract] [Full Text] [Related]

  • 16. Chronic allograft nephropathy and nephrotic range proteinuria.
    Ramanathan V, Suki WN, Rosen D, Truong LD.
    Clin Transplant; 2005 Jun; 19(3):413-7. PubMed ID: 15877807
    [Abstract] [Full Text] [Related]

  • 17. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP.
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [Abstract] [Full Text] [Related]

  • 18. Primary glomerulonephritis: an update on renal survival and determinants of progression.
    Moranne O, Watier L, Rossert J, Stengel B, GN-Progress Study Group.
    QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
    [Abstract] [Full Text] [Related]

  • 19. Posttransplant proteinuria is associated with higher risk of cardiovascular disease and graft failure in renal transplant patients.
    Ibis A, Akgül A, Ozdemir N, Colak T, Sezer S, Arat Z, Haberal M.
    Transplant Proc; 2009 Jun; 41(5):1604-8. PubMed ID: 19545689
    [Abstract] [Full Text] [Related]

  • 20. Renin-Angiotensin-Aldosterone system inhibitors and statins prolong graft survival in post-transplant glomerulonephritis.
    Pazik J, Ostrowska J, Lewandowski Z, Mróz A, Perkowska-Ptasińska A, Baczkowska T, Durlik M.
    Ann Transplant; 2008 Jun; 13(4):41-5. PubMed ID: 19034222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.